Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2015-06

AUTHORS

Marcos A. dos Santos, Jean-Pierre Pignon, Pierre Blanchard, Delphine Lefeuvre, Antonin Levy, Mehdi Touat, Guillaume Louvel, Frédéric Dhermain, Jean-Charles Soria, Eric Deutsch, Gwénaël Le Teuff

ABSTRACT

To perform a systematic review and meta-analysis of severe adverse events (SAE) reported in early trials combining molecularly targeted therapies (MTT) with radiotherapy (RT), and to compare them to standard therapy. A summary data meta-analysis was performed and compared to the historical standard. Inclusion criteria were phase I and/or II trials published between 2000 and 2011, with glioblastoma multiforme patients treated with RT and MTT. Pooled incidence rates (IR) of SAE were estimated as well as the pooled median progression-free survival (PFS) and overall survival (OS). Nineteen prospective trials (9 phase I, 1 phase I/II and 9 phase II) out of 29 initially selected were included (n = 755 patients). The exact number of patients who had experienced SAE was mentioned in 37 % of the trials, concerning only 17 % of the patients. Information such as the period during which adverse events were monitored, the planned treatment duration, and late toxicity were not reported in the trials. The pooled IR of overall SAE was 131.2 (95 % CI 88.8-193.7) per 1000 person-months compared to 74.7 (63.6-87.8) for standard therapy (p < 0.01). Significant differences were observed for gastrointestinal events (p = 0.05) and treatment-related deaths (p = 0.02), in favour of standard therapy. No significant difference was observed in PFS and OS. Reporting a summary of toxicity data in early clinical trials should be stringently standardized. The use of MTT with RT compared to standard therapy increased SAE while yielded comparable survival in glioblastoma multiforme patients. More... »

PAGES

307-314

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11060-015-1802-5

DOI

http://dx.doi.org/10.1007/s11060-015-1802-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1036714917

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25975195


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemoradiotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Trials, Phase I as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Trials, Phase II as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glioblastoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Molecular Targeted Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quality of Health Care", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy Dosage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Paris-Sud", 
          "id": "https://www.grid.ac/institutes/grid.5842.b", 
          "name": [
            "Department of Radiation Oncology, INSERM 1030 \u201cMolecular Radiotherapy\u201d, Gustave Roussy, Gustave Roussy Cancer Campus, 114 Rue \u00c9douard Vaillant, 94805, Villejuif Cedex, France", 
            "Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France", 
            "Facult\u00e9 de m\u00e9decine du Kremlin-Bic\u00eatre, Paris-Sud University, Kremlin Bic\u00eatre, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "dos Santos", 
        "givenName": "Marcos A.", 
        "id": "sg:person.010551327337.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010551327337.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for research in epidemiology and population health", 
          "id": "https://www.grid.ac/institutes/grid.463845.8", 
          "name": [
            "Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France", 
            "CESP Centre for Research in Epidemiology and Population Health, INSERM U1018, Paris-Sud University, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pignon", 
        "givenName": "Jean-Pierre", 
        "id": "sg:person.016652532434.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016652532434.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Paris-Sud", 
          "id": "https://www.grid.ac/institutes/grid.5842.b", 
          "name": [
            "Department of Radiation Oncology, INSERM 1030 \u201cMolecular Radiotherapy\u201d, Gustave Roussy, Gustave Roussy Cancer Campus, 114 Rue \u00c9douard Vaillant, 94805, Villejuif Cedex, France", 
            "CESP Centre for Research in Epidemiology and Population Health, INSERM U1018, Paris-Sud University, Villejuif, France", 
            "Facult\u00e9 de m\u00e9decine du Kremlin-Bic\u00eatre, Paris-Sud University, Kremlin Bic\u00eatre, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Blanchard", 
        "givenName": "Pierre", 
        "id": "sg:person.01133062702.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133062702.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lefeuvre", 
        "givenName": "Delphine", 
        "id": "sg:person.01137635233.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137635233.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Paris-Sud", 
          "id": "https://www.grid.ac/institutes/grid.5842.b", 
          "name": [
            "Department of Radiation Oncology, INSERM 1030 \u201cMolecular Radiotherapy\u201d, Gustave Roussy, Gustave Roussy Cancer Campus, 114 Rue \u00c9douard Vaillant, 94805, Villejuif Cedex, France", 
            "Drug Development Department, Gustave Roussy, Villejuif, France", 
            "Facult\u00e9 de m\u00e9decine du Kremlin-Bic\u00eatre, Paris-Sud University, Kremlin Bic\u00eatre, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Levy", 
        "givenName": "Antonin", 
        "id": "sg:person.01206241342.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206241342.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Radiation Oncology, INSERM 1030 \u201cMolecular Radiotherapy\u201d, Gustave Roussy, Gustave Roussy Cancer Campus, 114 Rue \u00c9douard Vaillant, 94805, Villejuif Cedex, France", 
            "Drug Development Department, Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Touat", 
        "givenName": "Mehdi", 
        "id": "sg:person.01163411361.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163411361.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Radiation Oncology, INSERM 1030 \u201cMolecular Radiotherapy\u201d, Gustave Roussy, Gustave Roussy Cancer Campus, 114 Rue \u00c9douard Vaillant, 94805, Villejuif Cedex, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Louvel", 
        "givenName": "Guillaume", 
        "id": "sg:person.01322177033.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322177033.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Radiation Oncology, INSERM 1030 \u201cMolecular Radiotherapy\u201d, Gustave Roussy, Gustave Roussy Cancer Campus, 114 Rue \u00c9douard Vaillant, 94805, Villejuif Cedex, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dhermain", 
        "givenName": "Fr\u00e9d\u00e9ric", 
        "id": "sg:person.0652067134.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652067134.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Paris-Sud", 
          "id": "https://www.grid.ac/institutes/grid.5842.b", 
          "name": [
            "Drug Development Department, Gustave Roussy, Villejuif, France", 
            "Facult\u00e9 de m\u00e9decine du Kremlin-Bic\u00eatre, Paris-Sud University, Kremlin Bic\u00eatre, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Soria", 
        "givenName": "Jean-Charles", 
        "id": "sg:person.01225022325.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225022325.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Paris-Sud", 
          "id": "https://www.grid.ac/institutes/grid.5842.b", 
          "name": [
            "Department of Radiation Oncology, INSERM 1030 \u201cMolecular Radiotherapy\u201d, Gustave Roussy, Gustave Roussy Cancer Campus, 114 Rue \u00c9douard Vaillant, 94805, Villejuif Cedex, France", 
            "Drug Development Department, Gustave Roussy, Villejuif, France", 
            "Facult\u00e9 de m\u00e9decine du Kremlin-Bic\u00eatre, Paris-Sud University, Kremlin Bic\u00eatre, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Deutsch", 
        "givenName": "Eric", 
        "id": "sg:person.0612431507.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612431507.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for research in epidemiology and population health", 
          "id": "https://www.grid.ac/institutes/grid.463845.8", 
          "name": [
            "Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France", 
            "CESP Centre for Research in Epidemiology and Population Health, INSERM U1018, Paris-Sud University, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Le Teuff", 
        "givenName": "Gw\u00e9na\u00ebl", 
        "id": "sg:person.01041607377.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01041607377.10"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1200/jco.2010.31.9236", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001460228"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2009.10.029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004898886"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.327.7414.557", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005003882"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/sim.1187", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005415550"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1740774512465495", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006544416"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1740774512465495", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006544416"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cad.0b013e328356f5b0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006578057"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cad.0b013e328356f5b0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006578057"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm200101113440207", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007928192"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.radonc.2013.06.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008439738"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2009.07.1741", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011053458"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.30.2729", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017963788"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-11-0120", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019815454"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2008.08.050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021366019"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2010.07.1997", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022221303"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-13-2098", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022891402"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2006.01.018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024728029"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-010-0390-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033114325", 
          "https://doi.org/10.1007/s11060-010-0390-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.26.6650", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033812582"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1308345", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036201464"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1017/s0266462305050154", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040305784"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.26.3541", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043187529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-009-0067-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043638462", 
          "https://doi.org/10.1007/s11060-009-0067-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-009-0067-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043638462", 
          "https://doi.org/10.1007/s11060-009-0067-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.18.0612", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043769312"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2008.03.046", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044924221"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-07-0047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045655350"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2008.05.062", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046384340"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1308573", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048225580"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.06.0269", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049849519"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2007.02.043", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051855329"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa043330", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052112015"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncponc0295", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052277585", 
          "https://doi.org/10.1038/ncponc0295"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncponc0295", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052277585", 
          "https://doi.org/10.1038/ncponc0295"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2011.06.474", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052837780"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2004.04.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053586523"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18637/jss.v036.i03", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068672546"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-141-10-200411160-00009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073707441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078579157", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-06", 
    "datePublishedReg": "2015-06-01", 
    "description": "To perform a systematic review and meta-analysis of severe adverse events (SAE) reported in early trials combining molecularly targeted therapies (MTT) with radiotherapy (RT), and to compare them to standard therapy. A summary data meta-analysis was performed and compared to the historical standard. Inclusion criteria were phase I and/or II trials published between 2000 and 2011, with glioblastoma multiforme patients treated with RT and MTT. Pooled incidence rates (IR) of SAE were estimated as well as the pooled median progression-free survival (PFS) and overall survival (OS). Nineteen prospective trials (9 phase I, 1 phase I/II and 9 phase II) out of 29 initially selected were included (n = 755 patients). The exact number of patients who had experienced SAE was mentioned in 37 % of the trials, concerning only 17 % of the patients. Information such as the period during which adverse events were monitored, the planned treatment duration, and late toxicity were not reported in the trials. The pooled IR of overall SAE was 131.2 (95 % CI 88.8-193.7) per 1000 person-months compared to 74.7 (63.6-87.8) for standard therapy (p < 0.01). Significant differences were observed for gastrointestinal events (p = 0.05) and treatment-related deaths (p = 0.02), in favour of standard therapy. No significant difference was observed in PFS and OS. Reporting a summary of toxicity data in early clinical trials should be stringently standardized. The use of MTT with RT compared to standard therapy increased SAE while yielded comparable survival in glioblastoma multiforme patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11060-015-1802-5", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094205", 
        "issn": [
          "0167-594X", 
          "1573-7373"
        ], 
        "name": "Journal of Neuro-Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "123"
      }
    ], 
    "name": "Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival", 
    "pagination": "307-314", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "aee579f468e390d3ce9ad1423bdf3a880c22b138851ca1a66c33c10d2920d5bc"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25975195"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309335"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11060-015-1802-5"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1036714917"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11060-015-1802-5", 
      "https://app.dimensions.ai/details/publication/pub.1036714917"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T17:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000533.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11060-015-1802-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11060-015-1802-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11060-015-1802-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11060-015-1802-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11060-015-1802-5'


 

This table displays all metadata directly associated to this object as RDF triples.

303 TRIPLES      21 PREDICATES      75 URIs      32 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11060-015-1802-5 schema:about N2072e6c7b97e4d3aa9e21a8be487d6b2
2 N2489e0ebfc2b468ca576d78da663cc0f
3 N3df1a13888384e42892916abd15f2ddf
4 N4d591042746a4720b2f2cc129078df45
5 N594557b7259442f9ae5f7e6f683bf397
6 N597a8f131cee4b5893ad490b6d71790b
7 N750c882a6b6748cfae911b7ca69344cf
8 N8b40bca588234120946483cc344affcf
9 N9161b8ecb8d84f16a6cfba2d31aec0d5
10 Nc115d98d2387411bb283c7843396c7d5
11 Ndbde6a10a6394cc9a7efd5c5357d7d3b
12 anzsrc-for:11
13 anzsrc-for:1103
14 schema:author Ne54f08927a7e41fb9355b00d41938414
15 schema:citation sg:pub.10.1007/s11060-009-0067-2
16 sg:pub.10.1007/s11060-010-0390-7
17 sg:pub.10.1038/ncponc0295
18 https://app.dimensions.ai/details/publication/pub.1078579157
19 https://doi.org/10.1002/sim.1187
20 https://doi.org/10.1016/j.ejca.2009.10.029
21 https://doi.org/10.1016/j.ijrobp.2004.04.023
22 https://doi.org/10.1016/j.ijrobp.2006.01.018
23 https://doi.org/10.1016/j.ijrobp.2007.02.043
24 https://doi.org/10.1016/j.ijrobp.2008.03.046
25 https://doi.org/10.1016/j.ijrobp.2008.05.062
26 https://doi.org/10.1016/j.ijrobp.2008.08.050
27 https://doi.org/10.1016/j.ijrobp.2009.07.1741
28 https://doi.org/10.1016/j.ijrobp.2010.07.1997
29 https://doi.org/10.1016/j.ijrobp.2011.06.474
30 https://doi.org/10.1016/j.radonc.2013.06.007
31 https://doi.org/10.1017/s0266462305050154
32 https://doi.org/10.1056/nejm200101113440207
33 https://doi.org/10.1056/nejmoa043330
34 https://doi.org/10.1056/nejmoa1308345
35 https://doi.org/10.1056/nejmoa1308573
36 https://doi.org/10.1097/cad.0b013e328356f5b0
37 https://doi.org/10.1136/bmj.327.7414.557
38 https://doi.org/10.1158/1078-0432.ccr-11-0120
39 https://doi.org/10.1158/1078-0432.ccr-13-2098
40 https://doi.org/10.1158/1535-7163.mct-07-0047
41 https://doi.org/10.1177/1740774512465495
42 https://doi.org/10.1200/jco.2006.06.0269
43 https://doi.org/10.1200/jco.2008.18.0612
44 https://doi.org/10.1200/jco.2009.26.3541
45 https://doi.org/10.1200/jco.2009.26.6650
46 https://doi.org/10.1200/jco.2010.30.2729
47 https://doi.org/10.1200/jco.2010.31.9236
48 https://doi.org/10.18637/jss.v036.i03
49 https://doi.org/10.7326/0003-4819-141-10-200411160-00009
50 schema:datePublished 2015-06
51 schema:datePublishedReg 2015-06-01
52 schema:description To perform a systematic review and meta-analysis of severe adverse events (SAE) reported in early trials combining molecularly targeted therapies (MTT) with radiotherapy (RT), and to compare them to standard therapy. A summary data meta-analysis was performed and compared to the historical standard. Inclusion criteria were phase I and/or II trials published between 2000 and 2011, with glioblastoma multiforme patients treated with RT and MTT. Pooled incidence rates (IR) of SAE were estimated as well as the pooled median progression-free survival (PFS) and overall survival (OS). Nineteen prospective trials (9 phase I, 1 phase I/II and 9 phase II) out of 29 initially selected were included (n = 755 patients). The exact number of patients who had experienced SAE was mentioned in 37 % of the trials, concerning only 17 % of the patients. Information such as the period during which adverse events were monitored, the planned treatment duration, and late toxicity were not reported in the trials. The pooled IR of overall SAE was 131.2 (95 % CI 88.8-193.7) per 1000 person-months compared to 74.7 (63.6-87.8) for standard therapy (p < 0.01). Significant differences were observed for gastrointestinal events (p = 0.05) and treatment-related deaths (p = 0.02), in favour of standard therapy. No significant difference was observed in PFS and OS. Reporting a summary of toxicity data in early clinical trials should be stringently standardized. The use of MTT with RT compared to standard therapy increased SAE while yielded comparable survival in glioblastoma multiforme patients.
53 schema:genre research_article
54 schema:inLanguage en
55 schema:isAccessibleForFree false
56 schema:isPartOf N3f3ca075002047f0960b1666615e797e
57 Naa917db582334513ae3b18cea38854f0
58 sg:journal.1094205
59 schema:name Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival
60 schema:pagination 307-314
61 schema:productId N127a33a8bf0641969f772c8010b41fbe
62 N1b55b34d3d5e4055a5aa56d88c20debe
63 N5177dc7c4b9d4c2a83a4d575d933462d
64 N9fe419a80bdc4dbdb2a784c4871f613b
65 Na43e709097624162acee377e2940e39e
66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036714917
67 https://doi.org/10.1007/s11060-015-1802-5
68 schema:sdDatePublished 2019-04-10T17:35
69 schema:sdLicense https://scigraph.springernature.com/explorer/license/
70 schema:sdPublisher Ne1a72a9951024f168da93e5c1921df06
71 schema:url http://link.springer.com/10.1007%2Fs11060-015-1802-5
72 sgo:license sg:explorer/license/
73 sgo:sdDataset articles
74 rdf:type schema:ScholarlyArticle
75 N0168df7aa9e0431c92c0d8e916831a5c rdf:first sg:person.01041607377.10
76 rdf:rest rdf:nil
77 N047cc9aa1ef648e5b742aec68cff1a34 rdf:first sg:person.016652532434.99
78 rdf:rest Nfc47d7c6af844e83960b6171642b50f0
79 N127a33a8bf0641969f772c8010b41fbe schema:name doi
80 schema:value 10.1007/s11060-015-1802-5
81 rdf:type schema:PropertyValue
82 N19f55f00ecc94df89c23476b9c1d38f8 rdf:first sg:person.01225022325.73
83 rdf:rest N295b2e626153466a917732278162c650
84 N1b55b34d3d5e4055a5aa56d88c20debe schema:name pubmed_id
85 schema:value 25975195
86 rdf:type schema:PropertyValue
87 N2072e6c7b97e4d3aa9e21a8be487d6b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Chemoradiotherapy
89 rdf:type schema:DefinedTerm
90 N2489e0ebfc2b468ca576d78da663cc0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Radiotherapy Dosage
92 rdf:type schema:DefinedTerm
93 N295b2e626153466a917732278162c650 rdf:first sg:person.0612431507.37
94 rdf:rest N0168df7aa9e0431c92c0d8e916831a5c
95 N3df1a13888384e42892916abd15f2ddf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Brain Neoplasms
97 rdf:type schema:DefinedTerm
98 N3f3ca075002047f0960b1666615e797e schema:issueNumber 2
99 rdf:type schema:PublicationIssue
100 N4d591042746a4720b2f2cc129078df45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Humans
102 rdf:type schema:DefinedTerm
103 N5177dc7c4b9d4c2a83a4d575d933462d schema:name readcube_id
104 schema:value aee579f468e390d3ce9ad1423bdf3a880c22b138851ca1a66c33c10d2920d5bc
105 rdf:type schema:PropertyValue
106 N594557b7259442f9ae5f7e6f683bf397 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Clinical Trials, Phase II as Topic
108 rdf:type schema:DefinedTerm
109 N597a8f131cee4b5893ad490b6d71790b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Prognosis
111 rdf:type schema:DefinedTerm
112 N6feb43890f8442788394b8942d9cee1b rdf:first sg:person.01206241342.36
113 rdf:rest Nb5c79272bf2344f2b71482a6db498074
114 N750c882a6b6748cfae911b7ca69344cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Clinical Trials, Phase I as Topic
116 rdf:type schema:DefinedTerm
117 N8b40bca588234120946483cc344affcf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Glioblastoma
119 rdf:type schema:DefinedTerm
120 N9161b8ecb8d84f16a6cfba2d31aec0d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Molecular Targeted Therapy
122 rdf:type schema:DefinedTerm
123 N9fe419a80bdc4dbdb2a784c4871f613b schema:name dimensions_id
124 schema:value pub.1036714917
125 rdf:type schema:PropertyValue
126 Na3c24209c8cb41b38d3f92e69a253c6f rdf:first sg:person.01322177033.66
127 rdf:rest Nb4c640d3d05942dfb4b00ef76c07af42
128 Na43e709097624162acee377e2940e39e schema:name nlm_unique_id
129 schema:value 8309335
130 rdf:type schema:PropertyValue
131 Na4c9e51f20fc41c6b55a647dacf836d4 rdf:first sg:person.01137635233.44
132 rdf:rest N6feb43890f8442788394b8942d9cee1b
133 Naa917db582334513ae3b18cea38854f0 schema:volumeNumber 123
134 rdf:type schema:PublicationVolume
135 Nb4c640d3d05942dfb4b00ef76c07af42 rdf:first sg:person.0652067134.98
136 rdf:rest N19f55f00ecc94df89c23476b9c1d38f8
137 Nb5c79272bf2344f2b71482a6db498074 rdf:first sg:person.01163411361.47
138 rdf:rest Na3c24209c8cb41b38d3f92e69a253c6f
139 Nc115d98d2387411bb283c7843396c7d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Quality of Health Care
141 rdf:type schema:DefinedTerm
142 Ndbde6a10a6394cc9a7efd5c5357d7d3b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Survival Rate
144 rdf:type schema:DefinedTerm
145 Ne1a72a9951024f168da93e5c1921df06 schema:name Springer Nature - SN SciGraph project
146 rdf:type schema:Organization
147 Ne54f08927a7e41fb9355b00d41938414 rdf:first sg:person.010551327337.71
148 rdf:rest N047cc9aa1ef648e5b742aec68cff1a34
149 Nfc47d7c6af844e83960b6171642b50f0 rdf:first sg:person.01133062702.16
150 rdf:rest Na4c9e51f20fc41c6b55a647dacf836d4
151 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
152 schema:name Medical and Health Sciences
153 rdf:type schema:DefinedTerm
154 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
155 schema:name Clinical Sciences
156 rdf:type schema:DefinedTerm
157 sg:journal.1094205 schema:issn 0167-594X
158 1573-7373
159 schema:name Journal of Neuro-Oncology
160 rdf:type schema:Periodical
161 sg:person.01041607377.10 schema:affiliation https://www.grid.ac/institutes/grid.463845.8
162 schema:familyName Le Teuff
163 schema:givenName Gwénaël
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01041607377.10
165 rdf:type schema:Person
166 sg:person.010551327337.71 schema:affiliation https://www.grid.ac/institutes/grid.5842.b
167 schema:familyName dos Santos
168 schema:givenName Marcos A.
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010551327337.71
170 rdf:type schema:Person
171 sg:person.01133062702.16 schema:affiliation https://www.grid.ac/institutes/grid.5842.b
172 schema:familyName Blanchard
173 schema:givenName Pierre
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133062702.16
175 rdf:type schema:Person
176 sg:person.01137635233.44 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
177 schema:familyName Lefeuvre
178 schema:givenName Delphine
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137635233.44
180 rdf:type schema:Person
181 sg:person.01163411361.47 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
182 schema:familyName Touat
183 schema:givenName Mehdi
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163411361.47
185 rdf:type schema:Person
186 sg:person.01206241342.36 schema:affiliation https://www.grid.ac/institutes/grid.5842.b
187 schema:familyName Levy
188 schema:givenName Antonin
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206241342.36
190 rdf:type schema:Person
191 sg:person.01225022325.73 schema:affiliation https://www.grid.ac/institutes/grid.5842.b
192 schema:familyName Soria
193 schema:givenName Jean-Charles
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225022325.73
195 rdf:type schema:Person
196 sg:person.01322177033.66 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
197 schema:familyName Louvel
198 schema:givenName Guillaume
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322177033.66
200 rdf:type schema:Person
201 sg:person.016652532434.99 schema:affiliation https://www.grid.ac/institutes/grid.463845.8
202 schema:familyName Pignon
203 schema:givenName Jean-Pierre
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016652532434.99
205 rdf:type schema:Person
206 sg:person.0612431507.37 schema:affiliation https://www.grid.ac/institutes/grid.5842.b
207 schema:familyName Deutsch
208 schema:givenName Eric
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612431507.37
210 rdf:type schema:Person
211 sg:person.0652067134.98 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
212 schema:familyName Dhermain
213 schema:givenName Frédéric
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652067134.98
215 rdf:type schema:Person
216 sg:pub.10.1007/s11060-009-0067-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043638462
217 https://doi.org/10.1007/s11060-009-0067-2
218 rdf:type schema:CreativeWork
219 sg:pub.10.1007/s11060-010-0390-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033114325
220 https://doi.org/10.1007/s11060-010-0390-7
221 rdf:type schema:CreativeWork
222 sg:pub.10.1038/ncponc0295 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052277585
223 https://doi.org/10.1038/ncponc0295
224 rdf:type schema:CreativeWork
225 https://app.dimensions.ai/details/publication/pub.1078579157 schema:CreativeWork
226 https://doi.org/10.1002/sim.1187 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005415550
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1016/j.ejca.2009.10.029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004898886
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1016/j.ijrobp.2004.04.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053586523
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1016/j.ijrobp.2006.01.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024728029
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/j.ijrobp.2007.02.043 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051855329
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/j.ijrobp.2008.03.046 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044924221
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1016/j.ijrobp.2008.05.062 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046384340
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1016/j.ijrobp.2008.08.050 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021366019
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1016/j.ijrobp.2009.07.1741 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011053458
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1016/j.ijrobp.2010.07.1997 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022221303
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1016/j.ijrobp.2011.06.474 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052837780
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1016/j.radonc.2013.06.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008439738
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1017/s0266462305050154 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040305784
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1056/nejm200101113440207 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007928192
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1056/nejmoa043330 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052112015
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1056/nejmoa1308345 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036201464
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1056/nejmoa1308573 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048225580
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1097/cad.0b013e328356f5b0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006578057
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1136/bmj.327.7414.557 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005003882
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1158/1078-0432.ccr-11-0120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019815454
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1158/1078-0432.ccr-13-2098 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022891402
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1158/1535-7163.mct-07-0047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045655350
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1177/1740774512465495 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006544416
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1200/jco.2006.06.0269 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049849519
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1200/jco.2008.18.0612 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043769312
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1200/jco.2009.26.3541 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043187529
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1200/jco.2009.26.6650 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033812582
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1200/jco.2010.30.2729 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017963788
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1200/jco.2010.31.9236 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001460228
283 rdf:type schema:CreativeWork
284 https://doi.org/10.18637/jss.v036.i03 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068672546
285 rdf:type schema:CreativeWork
286 https://doi.org/10.7326/0003-4819-141-10-200411160-00009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073707441
287 rdf:type schema:CreativeWork
288 https://www.grid.ac/institutes/grid.14925.3b schema:alternateName Institut Gustave Roussy
289 schema:name Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France
290 Department of Radiation Oncology, INSERM 1030 “Molecular Radiotherapy”, Gustave Roussy, Gustave Roussy Cancer Campus, 114 Rue Édouard Vaillant, 94805, Villejuif Cedex, France
291 Drug Development Department, Gustave Roussy, Villejuif, France
292 rdf:type schema:Organization
293 https://www.grid.ac/institutes/grid.463845.8 schema:alternateName Centre for research in epidemiology and population health
294 schema:name CESP Centre for Research in Epidemiology and Population Health, INSERM U1018, Paris-Sud University, Villejuif, France
295 Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France
296 rdf:type schema:Organization
297 https://www.grid.ac/institutes/grid.5842.b schema:alternateName University of Paris-Sud
298 schema:name CESP Centre for Research in Epidemiology and Population Health, INSERM U1018, Paris-Sud University, Villejuif, France
299 Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France
300 Department of Radiation Oncology, INSERM 1030 “Molecular Radiotherapy”, Gustave Roussy, Gustave Roussy Cancer Campus, 114 Rue Édouard Vaillant, 94805, Villejuif Cedex, France
301 Drug Development Department, Gustave Roussy, Villejuif, France
302 Faculté de médecine du Kremlin-Bicêtre, Paris-Sud University, Kremlin Bicêtre, France
303 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...